| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/03/1997 | EP0792283A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792169A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792166A1 Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/03/1997 | CN1158617A RNA component of telomerase |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031115A2 Synthetic hiv genes |
| 08/28/1997 | WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 08/28/1997 | WO1997031111A2 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them |
| 08/28/1997 | WO1997031108A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | WO1997030732A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | WO1997030731A2 Method of preparing polynucleotide-carrier complexes for delivery to cells |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997020935A3 Viral vectors |
| 08/28/1997 | WO1997020051A3 Vectors and methods for gene transfer to cells |
| 08/28/1997 | WO1997019180A3 Vector consisting of a transcriptional regulatory DNA sequence linked to a DNA sequence encoding beta-lactamase for enzyme prodrug therapy |
| 08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
| 08/28/1997 | CA2247517A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2245646A1 Synthetic hiv genes |
| 08/28/1997 | CA2241142A1 Liposomal-viral dna complexes for treating disease |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791064A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791060A2 Ribozyme analogs |
| 08/27/1997 | EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 08/27/1997 | EP0791050A1 Vectors for tissue-specific replication |
| 08/27/1997 | EP0791010A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/26/1997 | US5661132 Delivery to wound a dna-coated gold bead genetic construct which encodes epidermal growth factor |
| 08/26/1997 | US5661126 Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
| 08/26/1997 | US5661032 Controller of transcription of marker gene |
| 08/26/1997 | US5661025 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 08/26/1997 | US5660825 Treating autoimmune disorders by administering protein complex deactivator |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030167A1 Method of treating liver disorders |
| 08/21/1997 | WO1997030157A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | WO1997030155A1 Gene therapy method using fgf-5 |
| 08/21/1997 | WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030108A1 Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins |
| 08/21/1997 | WO1997030083A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030066A1 NOVEL PENILE NEURONAL NITRIC OXIDE SYNTHASE (PnNOS) AND APPLICATIONS FOR DIAGNOSIS AND TREATMENT OF UROGENITAL DISORDERS |
| 08/21/1997 | WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | WO1997030058A1 Phosphatidyl oligoglycerols |
| 08/21/1997 | WO1997029781A1 Methods and compositions for modulating an immune response |
| 08/21/1997 | WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | WO1997029757A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997017369A3 Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | DE19622224A1 Phosphatidyloligoglycerine Phosphatidyloligoglycerols |
| 08/21/1997 | CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | CA2246578A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | CA2246503A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | CA2245503A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790313A2 Nucleic acid constructs for the cell cycle regulated expression of genes, cells comprising said constructs and their use for the preparation of medical compositions |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0790305A1 Mutant human growth hormones and their uses |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789762A1 Methods for the diagnosis of glaucoma |
| 08/20/1997 | EP0789757A1 Transgenic organisms and their uses |
| 08/20/1997 | EP0789708A1 Multifunctional molecular complexes for gene transfer to cells |
| 08/20/1997 | EP0789706A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789592A1 Ocular gene therapy |
| 08/20/1997 | EP0789591A1 Methods for identifying individuals suffering from a cellular abnormality |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789564A1 Polynucleotide compositions |
| 08/20/1997 | EP0789563A1 Hepatitis virus vaccines |
| 08/20/1997 | EP0452457B1 Method of in vivo delivery of functioning foreign genes |
| 08/19/1997 | US5658892 Compound delivery using high-pressure impulse transients |
| 08/19/1997 | US5658891 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 08/19/1997 | US5658786 DNA encoding rat taurine transporter and uses thereof |
| 08/19/1997 | US5658785 Adeno-associated virus materials and methods |
| 08/19/1997 | US5658780 Rel a targeted ribozymes |
| 08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658729 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658567 Recombinant glycosylated biologically active human alpha-galactosidase a obtained by culturing host cell comprising recombinant baculovirus comprising nucleic acid encoding said enzyme, recovering |